Development of local clinical practice guidelines in the real world: an evolving scene in China.
作者信息
Kwong Joey Sw, Sun Xin
机构信息
Chinese Evidence-Based Medicine Center and Chinese Cochrane Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
出版信息
Heart Asia. 2017 Jun 16;9(2):e010903. doi: 10.1136/heartasia-2017-010903. eCollection 2017.
Abstract
摘要
相似文献
1
Development of local clinical practice guidelines in the real world: an evolving scene in China.
Heart Asia. 2017 Jun 16;9(2):e010903. doi: 10.1136/heartasia-2017-010903. eCollection 2017.
2
Lipid-lowering therapy in patients with coronary artery disease undergoing percutaneous coronary interventions in Italy: an expert opinion paper of Interventional Cardiology Working Group of Italian Society of Cardiology.
J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e86-e94. doi: 10.2459/JCM.0000000000001440.
3
Consensus Statement on Coronary Intervention during the Coronavirus Disease 2019 (COVID-19) Pandemic: from the Korean Society of Interventional Cardiology (KSIC).
Korean Circ J. 2020 Nov;50(11):974-983. doi: 10.4070/kcj.2020.0283.
4
The year in review: advances in interventional cardiology in 2019.
Curr Opin Cardiol. 2020 Jul;35(4):325-331. doi: 10.1097/HCO.0000000000000752.
5
Comparison of interventional cardiology in two European countries: a nationwide Internet based registry study.
Int J Cardiol. 2013 Sep 30;168(2):1237-42. doi: 10.1016/j.ijcard.2012.11.054. Epub 2012 Dec 8.
6
Major Global Coronary Artery Calcium Guidelines.
JACC Cardiovasc Imaging. 2023 Jan;16(1):98-117. doi: 10.1016/j.jcmg.2022.06.018. Epub 2022 Sep 14.
7
Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART.
JACC Cardiovasc Imaging. 2018 Sep;11(9):1301-1310. doi: 10.1016/j.jcmg.2018.06.021.
8
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19.
9
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery disease.
Can J Cardiol. 2014 Dec;30(12):1482-91. doi: 10.1016/j.cjca.2014.09.034. Epub 2014 Oct 5.
10
A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry - XIENCE V performance evaluation (THRIVE study).
Indian Heart J. 2017 Mar-Apr;69(2):165-169. doi: 10.1016/j.ihj.2016.10.008. Epub 2016 Oct 26.
引用本文的文献
1
Evidence-based medicine in China.
Chronic Dis Transl Med. 2019 Mar 20;5(1):1-5. doi: 10.1016/j.cdtm.2019.02.001. eCollection 2019 Mar.
2
Real world evidence: experience and lessons from China.
BMJ. 2018 Feb 5;360:j5262. doi: 10.1136/bmj.j5262.
本文引用的文献
1
Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp).
PLoS Med. 2017 Jan 10;14(1):e1002207. doi: 10.1371/journal.pmed.1002207. eCollection 2017 Jan.
2
[2016 Chinese guideline for the management of dyslipidemia in adults].
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Oct 24;44(10):833-853. doi: 10.3760/cma.j.issn.0253-3758.2016.10.005.
3
[Chinese guideline for percutaneous coronary intervention(2016)].
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 May 24;44(5):382-400. doi: 10.3760/cma.j.issn.0253-3758.2016.05.006.
4
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China.
Am Heart J. 2016 May;175:193-201.e3. doi: 10.1016/j.ahj.2015.04.014. Epub 2015 Apr 17.
5
Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.
JAMA Intern Med. 2016 Apr;176(4):512-21. doi: 10.1001/jamainternmed.2016.0166.
6
Caring for Coronary Artery Disease in China: Managing Modernization.
JAMA Intern Med. 2016 Apr;176(4):521-3. doi: 10.1001/jamainternmed.2016.0198.
7
The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.
Catheter Cardiovasc Interv. 2016 Dec;88(7):E212-E221. doi: 10.1002/ccd.26461. Epub 2016 Mar 4.
8
Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
JACC Cardiovasc Interv. 2016 Jan 11;9(1):89-96. doi: 10.1016/j.jcin.2015.09.026. Epub 2015 Dec 9.
9
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.
J Am Coll Cardiol. 2015 Dec 1;66(21):2298-2309. doi: 10.1016/j.jacc.2015.09.054. Epub 2015 Oct 12.
10
Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system.
Lancet. 2015 Oct 10;386(10002):1493-505. doi: 10.1016/S0140-6736(15)00343-8.
Zotero 插件